DraftKings and FanDuel Have Been Great Bets. As the NFL Season Nears, Investors Need a Strong Defense.

Top catalysts for S&P 500 (VOO), Nasdaq 100 (QQQ), Dow Jones (DIA) next week

Here's why the Alibaba stock price has gone parabolic

Now Is The Time To Buy This High-Yielding Trio

T-Mobile: Primed For All-Time Highs

Thor Industries: Stretched Valuation, Tough Quarters Ahead, Limited Long-Term Upside

First Phosphate raises $2.3M to fund Quebec exploration plans - ICYMI

Everyone's Wrong About Nvidia

Tech Corner: UBER's Autonomous Driving Outlook

Rheinmetall: Europe's Ammunition Powerhouse And Strong Buy Defense Investment

NVIDIA Market Cap Tops Microsoft By $470 Billion

Got $1,000 to Invest This September? These Ultra-High-Yielding Dividend Stocks Could Turn It Into Over $60 of Annual Passive Income.

These 3 oversold stocks are primed for significant gains

Medicus Pharma nears FDA milestone in cancer trial - ICYMI

DICKS's Sporting Goods Stock Dropped After Earnings—Is It a Buy?

Micron, Boeing Lead Five Stocks Near Buy Points

Will 2025's 3 Best-Performing "Ten Titans" Stocks Lead the Group Again in 2026?

Prediction: This Artificial Intelligence (AI) Semiconductor Stock Will Join Nvidia, Microsoft, Apple, Alphabet, and Amazon in the $2 Trillion Club by 2028. (Hint: Not Broadcom)

Could Cracker Barrel, SuperMicro, and Opendoor be the next meme stocks?

Daiichi Sankyo Announces the Development of a Fixed-Triple Combination Lipid-Lowering Tablet to Address Persistent Gaps in the Management of Elevated LDL-C

One Pick for a Narrow Bull Market

Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C

CHTR Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges CHTR Investors with Losses to Contact the Firm

OPP: The Preferred Shares Are A Good Deal

Why Scott Mushkin doesn't like anything in retail but Dollar Tree stock

Is Archer Aviation Stock A Sleeper Hit In The Flying Car Wars?

UnitedHealth: Path To $400+ By FY 2026 End

Highland Critical Minerals streamlines assets with spinout of Highland Red Lake Gold - ICYMI

Novartis Leqvio® shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain

Engines to AI: Cummins' Surprising Growth Driver

Hillenbrand: Portfolio Transformation, Discounted Valuation, And Cyclical Recovery Set To Drive Upside

Carpenter Technology: The Strong Bottom Line Could Drive Further Gains (Rating Upgrade)

Zscaler Q4 Earnings Preview: Rising On CrowdStrike's Coattails

Industry-Leading Margins And Record Cash Flow Position Newmont For Long-Term Value Creation

VOO Vs VOOG: What's a Better Pick for My Retirement Portfolio?

Universal Health Realty: FFO May Reach $3.60/Share In 2026

Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension

Big Discounts, Bigger Income

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension

3 Stocks Billionaires Bought Last Month

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

AstraZeneca to seek approval for blood pressure drug by year-end

3 Super-Reliable Real Estate Stocks to Buy and Hold for Passive Income

3 Dividend Growth Stocks That Can Double Your Income

If You'd Invested $10,000 in Nvidia Stock 10 Years Ago, Here's How Much You'd Have Today

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Flywire Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLYW

GoDaddy: Embracing AI To Improve Products And Margins

Goldman Sachs No. 2 just sold $13.6M in stock: here's what it really means

New Motley Fool Research Reveals the 10 Largest Consumer Staple Companies. Here's Which Dividend King Is Still Flying Under the Radar.

Ocean Power Technologies grows Middle East footprint with Unique Group - ICYMI

Realty Income: King Of REITs Still Offers Viable Monthly Incomes

Nvidia is caught in the middle of the 'US-China technology competition'

National Presto Industries: An Upgrade Is Justified

Alphabet's AI Moat: Why The Market Is Undervaluing A Giant

Want AI Exposure Without the Hype? This Stock Is a No-Brainer Buy

Permian Resources: Undervalued Permian Pureplay With A Dividend Yield Above 4%

Why Nvidia's 4% Stock Stumble Is the Steal of the Century

Accelerating Growth In AI And Cloud Makes Tencent Still A Buy

Tesla Rival BYD Hits A Home Run

Porsche 2026 Macan EV gets digital key sharing, AI voice control and automatic parking

Using NVDA Options in "Slower and Steadier" Trade, AVGO "Sneaky" A.I. Player

Incyte: Wall Street Underestimates Strength Of Ruxolitinib Portfolio

4 "Ten Titans" Stocks Are Already in the Dow Jones. Could the Rest Join by 2030?

If You Like LandBridge, You May Love WaterBridge

Tompkins Financial Corporation: Balance Sheet Repricing Remains An Ongoing Tailwind

American Resources CEO discusses ReElement Technologies' partnership with Principal Minerals - ICYMI

2 Blue-Chip Behemoths For Retirement Income

Weekly wrap: markets wobble, Trump battles Fed, Nvidia smashes records, Musk faces SEC heat

Smaller Industrials Names Seeing Surging Growth: Here's Why

Walmart's latest AI innovations represent a shift for big retail

Down 50%, Should You Buy the Dip on C3.ai?

Marvell: Load Up Now While The Market Runs For Cover

Elliott sees opportunities to create value at warehouse REIT Rexford Industrial

4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizer

Top 2 sports betting stocks to buy ahead of NFL season

CAPR DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPR

Should You Buy Nu Holdings While It's Below $15?

New REDUCE-IT® Analyses Presented at ESC 2025 Include Data Showing VASCEPA®/VAZKEPA® (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups

Nvidia has $57 billion in cash. Wall Street has ideas about what to do with it.

Top 5 Dividend Stocks Yielding Over 5% for Effortless Passive Income

U.S. Gold secures power deal for CK Gold Project - ICYMI

Green Plains: Transforming Ethanol Production From Zero To Hero

The 5 Best Dividend Stocks to Buy Now

Rolls-Royce weighs funding options, including IPO, for small nuclear unit, FT reports

PTY: Attractive Valuation And Growth Potential From Interest Rate Cuts

REET Vs. VNQ: Investing In REITs Should Come With Global Diversification

Zscaler: Paying Up For The Future Of Cybersecurity

General Motors (NYSE: GM) Price Prediction and Forecast 2025-2030 (September 2025)

Always Buy Simon Property Group's Preferred Stock When It Is Reasonably Priced

Need $2000 in Passive Income? Invest Just $5000 in 3 Strong-Buy Rated Stocks

Is Oklo Stock a Buy Now?

ANRO DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ANRO

If You'd Invested $1,000 in CRLBF 5 Years Ago, Here's How Much You'd Have Today

Capturing AI's Upside: ARTY's Concentrated Play On Tomorrow's Winners

Tilray Brands: Momentum Now, Fundamentals Later

2 Top AI Stocks Prominent Billionaires Are Buying

Acoramidis Demonstrates Statistically Significant Reduction in Cardiovascular Mortality (CVM) through Month 42 of the ATTRibute-CM Open Label Extension

Micron: Time To Jump Back On The AI Bullet Train (Rating Upgrade)

Huge News for Qualcomm Investors

SLYG: Skewed Towards Tariff Trouble